an emerging pathogen causing cavitary lung lesions.

Juhi Taneja, Kuhu Chatterjee, Ruchi Arora Sachdeva, S Zafar Abbas, M K Sen
Author Information
  1. Juhi Taneja: Department of Microbiology, ESIC Medical College and Hospital, Faridabad, Haryana, India. ORCID
  2. Kuhu Chatterjee: Department of Microbiology, ESIC Medical College and Hospital, Faridabad, Haryana, India.
  3. Ruchi Arora Sachdeva: Department of Respiratory Medicine, ESIC Medical College and Hospital, Faridabad, Haryana, India.
  4. S Zafar Abbas: Department of Radiology, ESIC Medical College and Hospital, Faridabad, Haryana, India.
  5. M K Sen: Department of Respiratory Medicine, ESIC Medical College and Hospital, Faridabad, Haryana, India.

Abstract

Introduction: is an emerging pathogen that causes pulmonary mucormycosis.
Case Presentation: We report a case of pneumonia caused by in a 54-year-old type 2 diabetic patient. The organism was isolated from bronchoalveolar lavage fluid and preliminarily identified by fungal morphology and finally by sequencing of the internal transcribed spacer region.
Conclusion: Mucormycosis may be associated with cavitary lung lesions against a backdrop of poorly controlled diabetes or other immunosuppressed states. Pulmonary mucormycosis may have variable clinical and radiological presentations. Therefore, strong clinical suspicion and prompt management can address the high fatality associated with the disease.

Keywords

References

  1. Mol Biol Evol. 2018 Jun 1;35(6):1547-1549 [PMID: 29722887]
  2. J Clin Invest. 2010 Jun;120(6):1914-24 [PMID: 20484814]
  3. J Clin Microbiol. 2010 May;48(5):1965-9 [PMID: 20200286]
  4. Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15 [PMID: 31811914]
  5. J Fungi (Basel). 2019 Mar 21;5(1): [PMID: 30901907]
  6. Lancet Infect Dis. 2019 Dec;19(12):e405-e421 [PMID: 31699664]
  7. Clin Infect Dis. 2012 Feb;54 Suppl 1:S16-22 [PMID: 22247441]
  8. Indian J Med Microbiol. 2021 Oct-Dec;39(4):473-474 [PMID: 34266698]
  9. Med Mycol. 2019 Jun 1;57(4):395-402 [PMID: 30085158]
  10. Respir Care. 2013 May;58(5):e60-3 [PMID: 23107233]
  11. J Fungi (Basel). 2018 Apr 06;4(2): [PMID: 29642408]
  12. Respirology. 2012 Aug;17(6):913-26 [PMID: 22335254]
  13. Med Mycol. 2018 Apr 1;56(suppl_1):93-101 [PMID: 29538730]
  14. J Infect Dis. 2005 Apr 15;191(8):1350-60 [PMID: 15776383]
  15. Indian J Med Microbiol. 2022 Jan-Mar;40(1):175 [PMID: 34848327]
  16. Clin Infect Dis. 2014 Mar;58(5):672-8 [PMID: 24352351]
  17. J Fungi (Basel). 2020 Nov 02;6(4): [PMID: 33147877]
  18. Mycopathologia. 2017 Oct;182(9-10):907-913 [PMID: 28580534]

Word Cloud

Created with Highcharts 10.0.0mucormycosiscavitaryemergingpathogenpulmonarymayassociatedlunglesionsclinicalIntroduction:causesCasePresentation:reportcasepneumoniacaused54-year-oldtype2diabeticpatientorganismisolatedbronchoalveolarlavagefluidpreliminarilyidentifiedfungalmorphologyfinallysequencinginternaltranscribedspacerregionConclusion:MucormycosisbackdroppoorlycontrolleddiabetesimmunosuppressedstatesPulmonaryvariableradiologicalpresentationsThereforestrongsuspicionpromptmanagementcanaddresshighfatalitydiseasecausingRhizopushomothallicus

Similar Articles

Cited By